Galapagos NV
GLPG
#4956
Rank
โ‚น178.18 B
Marketcap
โ‚น2,653
Share price
0.00%
Change (1 day)
8.20%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -โ‚น37.14

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น38.98. In 2024 the company made an earnings per share (EPS) of โ‚น111.51 a decrease over its 2023 EPS that were of โ‚น339.52.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น37.14
2024โ‚น111.51-67.16%
2023โ‚น339.52-199.64%
2022-โ‚น340.7499.03%
2021-โ‚น171.21-68.98%
2020-โ‚น551.94-298.06%
2019โ‚น278.68-554.64%
2018-โ‚น61.30-77.18%
2017-โ‚น268.64-326.21%
2016โ‚น118.76-134.19%
2015-โ‚น347.33-371.34%
2014โ‚น128.00-445.98%
2013-โ‚น37.0032.88%
2012-โ‚น27.84-82.07%
2011-โ‚น155.32-817.9%
2010โ‚น21.6412.73%
2009โ‚น19.19-120.79%
2008-โ‚น92.29-37.67%
2007-โ‚น148.0939.64%
2006-โ‚น106.0528.17%
2005-โ‚น82.746.25%
2004-โ‚น77.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น835.89-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น345.27-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น196.76-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น244.91-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น340.37-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น664.98-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น371.84-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น58.36 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น131.08-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel